Dr. Cynthia Cherfane, MD

Dr. Cherfane practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Cherfane's NPI, 1154619559, was assigned on July 19, 2011. Dr. Cherfane graduated from St Joseph's University Medical School in 2010. Dr. Cherfane holds California license A172436.

Dr. Cherfane's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Cherfane's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Cherfane is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Cherfane to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cherfane practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Cherfane's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Cherfane is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Cherfane's licenses on file in 4 states: California, Missouri, Pennsylvania and Iowa.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Cherfane treats.

CMS data shows 251 Medicare services from Dr. Cherfane across 9 procedure codes in 2024, for 160 Medicare patients. Medicare paid $25,663 for them.

CMS counts 160 Medicare patients who saw Dr. Cherfane in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cherfane's median patient age at 53, with 55% women.

In 2024, Dr. Cherfane wrote 249 Medicare Part D claims for 73 patients. 80% of them were for generic drugs. CMS names the drug for 152 of them, across 7 drugs with 11 or more claims each, at $5,756 in total drug cost. In 2023, CMS named 88 claims across 4 drugs.

Dr. Cherfane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cherfane as offering telehealth. CMS counts 89 procedures of colonoscopy by Dr. Cherfane, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Cherfane, published from 2013 to 2020. Dr. Cherfane's most frequent co-authors are David G. Binion, MD, Kyle E. Brown, MD and Benjamin H. Click, MD.

CMS Open Payments shows 46 general payments to Dr. Cherfane from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,101.

Dr. Cherfane graduated from St Joseph's University Medical School in 2010.

Dr. Cherfane is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.